Objective To determine the prevalence of self-reported use of illegal psychoactive substances in a homeless population of the city of Cali. Method Descriptive study of prevalence of period. The target population was 763 homeless people registered during 2010 in the database provided by a temporary shelter facility in the city of Cali. Statistical analysis was performed using R version 3.2.0. Research safe according to the resolution 8430 of 1993. Results 76.9 % of the homeless population recognizes that they consume some type of illegal psychoactive substance (IPAS). The substances with a higher prevalence of use in this population were: marijuana (51.2 %), the crack cocaine (44.6 %) and cocaine (11.3 %). 28.6 % of homeless people were found to consume IPAS more than three times a day and that the main route of administration is smoke (54.7 %). 50% of respondents reported having been hospitalized at some time in a rehabilitation center. Discussion The results in this study show that the problem of PASI consumption significantly affects the population of homeless people, with marijuana and crack cocaine being the most commonly used, which is a complex situation if the easy access of these substances and the severe physical and mental degenerative effects the cause in those who consume them are taken into account. Therefore it is necessary to support initiatives aimed at intervening in this social phenomenon.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.15446/rsap.v17n2.30016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
NMR Spectroscopic Reference Data of Synthetic Cannabinoids Sold on the Internet.
Magn Reson Chem
January 2025
Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Graz, Graz, Austria.
Besides classic illegal drugs, numerous designer drugs, also called new psychoactive substances (NPSs), are available on the global drug market. One of the biggest and fastest-growing substance classes comprises the synthetic cannabinoids. According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 254 out of 950 monitored substances belong to this group of NPS, with 9 new cannabinoids registered for the first time in 2023.
View Article and Find Full Text PDFThe French Addictovigilance Network - A multidisciplinary successful journey in the protection of public health.
Therapie
December 2024
Healthcare Data, Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands; iMed.ULisboa - Research Institute for Medicines, Faculty of Pharmacy, University of Lisbon, Avenida Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address:
Since the beginning of the century, the USA have been experiencing an opioid epidemic characterised by high levels of prescription opioid use. While extensive North American literature on the topic has been published and several public health measures implemented attempting to address the problem, in Europe addiction research, especially literature focusing on misuse of medicines, lags far behind. France is an exception: it is the only European country that has established a nationwide specific system to monitor misuse of legal and illegal psychoactive substances, an activity that has been named addictovigilance.
View Article and Find Full Text PDFNuclear Magnetic Resonance Spectroscopic Characterization and Determination of the New Psychoactive Substance Benzylone: Application in a Biological Fluid.
Magn Reson Chem
December 2024
Department of Chemistry, NMR Centre, Laboratory of Analytical Chemistry, University of Ioannina, Ioannina, Greece.
New psychoactive substances (NPS)-designed to mimic various legal or illegal substances-are an emerging worldwide health problem. Their identification and quantification in either complex seized samples or powders are critical; moreover, their determination in biological fluids is an intriguing goal in the forensic toxicology field. Synthetic cathinones are one of the most important groups among NPS.
View Article and Find Full Text PDFEstablishment of Broad-Specificity Monoclonal Antibody-Based Immunoassay for Rapid Detection of Indole-Type and Indazole-Type Synthetic Cannabinoids and Metabolites.
Anal Chem
November 2024
Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
Article Synopsis
- Synthetic cannabinoids (SCs) are widely abused new psychoactive substances that significantly threaten public health, with new variants lacking proper detection methods.
- Researchers developed monoclonal antibodies targeting 36 different indole-type and indazole-type SCs and their metabolites, detailing how these antibodies recognize the substances.
- They established two detection methods, ic-ELISA and GICA, which can effectively identify specific SCs in urine and hair samples, achieving low detection limits for multiple SC variants.
Prenatal buprenorphine/naloxone exposure and neonatal neurobehavioral functioning: A preliminary report.
Neurotoxicol Teratol
December 2024
Johns Hopkins University School of Medicine, Department of Pediatrics, USA.
Article Synopsis
- - The study examines the neurobehavioral functioning of neonates exposed to buprenorphine/naloxone during pregnancy, addressing the lack of research on the effects of this medication combination on infants.
- - Data was collected from mothers undergoing treatment for opioid use disorder, with the neonates assessed at three different points in their first month of life using the NICU Network Neurobehavioral Scale (NNNS).
- - Results highlighted various neurobehavioral domains affected in these infants and identified maternal factors, such as high rates of smoking and psychiatric disorders, that may impact neonatal development.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!